Research Article: Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)
Introduction:
Patients with severe persistent asthma represent the highest unmet medical need among the asthmatic population. , Severe asthma, as defined by GINA, is asthma that is uncontrolled despite adherence with optimized high-dose ICS-LABA treatment and management of contributory factors, or that worsens when high-dose treatment is decreased. A common phenotype, eosinophilic asthma, is associated with persistent eosinophilic inflammation, late onset of disease, impaired lung function, poor asthma control, recurrent…
Read more